LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Debt / NOTE 5.250%12/0
Market price (% of par)
111.95%
Total 13F principal
$88,209,000
Principal change
$0
Total reported market value
$98,475,785
Number of holders
10

Institutional Holders of LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 as of Q4 2018

As of 31 Dec 2018, LEXICON PHARMACEUTICALS INC - NOTE 5.250%12/0 was held by 10 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $88,209,000 in principal (par value) of the bond. The largest 10 bondholders included CITADEL ADVISORS LLC, Polygon Management Ltd., LAZARD ASSET MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, UBS ASSET MANAGEMENT AMERICAS INC, DEUTSCHE BANK AG\, DeepCurrents Investment Group LLC, Verition Fund Management LLC, JPMORGAN CHASE & CO, and MACKAY SHIELDS LLC. This page lists 10 institutional bondholders reporting positions for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.